跳至主要内容
临床试验/EUCTR2013-000309-21-IT
EUCTR2013-000309-21-IT进行中(未招募)不适用

Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary Tract - PREDICT_Trial

AOU di Bologna, Policlinico S.Orsola-Malpighi0 个研究点目标入组 436 人开始时间: 2013年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
436

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a.Age between 1 and 4 months
  • b.Gestational age > 35 weeks
  • c.Glomerular filtration rate (calculated according to Schwartz) > 15 ml/min/1.73 m2 at three months of age
  • d.No previous symptomatic UTI
  • e.Imaging Diagnostic work-up completed and presence of grade III to V vesico-ureteral reflux
  • f.Informed consent of parents
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 436
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • a.Age <1 and >4 months
  • b.Gestational age < 35 weeks
  • c.Glomerular filtration rate (calculated according to Schwartz) < 15 ml/min/1.73 m2 at three months of age
  • d.Patients with neurogenic bladder, myelomeningocele, uretero-pelvic junction and/or uretero-vescico junction obstruction, or other malformations leading to potential voiding disturbances, apart from urethral valves
  • e.Patients with no or low grade reflux (grade I and II).
  • f.Hypersensitivity to the all the utilized antimicrobial agent
  • g.Children with serious clinical conditions which, according to the investigator, prevent them from being included in the study cohort.
  • h.Use of experimental drugs in the month previous to the beginning of the study
  • i.Children unable to follow the established protocol procedures or whose parents are unable to sign the informed consent.

研究者

发起方
AOU di Bologna, Policlinico S.Orsola-Malpighi

相似试验

进行中(未招募)
不适用
Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary TractEvaluation of the effectiveness of antimicrobial prophylaxis in infants with vesico-ureteral reflux grade III-V, started before the first symptomatic infectionMedDRA version: 17.1Level: LLTClassification code 10047371Term: Vesicoureteral refluxSystem Organ Class: 100000004857
EUCTR2013-000309-21-ESAOU di Bologna, Policlinico S.Orsola-Malpighi436
进行中(未招募)
1 期
Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary Tract
EUCTR2013-000309-21-SEAOU di Bologna, Policlinico S.Orsola-Malpighi436
进行中(未招募)
1 期
Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary Tractevaluation of the effectiveness of antimicrobial prophylaxis in infants with vesico-ureteral reflux grade III-V, started before the first symptomatic infectionMedDRA version: 20.0Level: LLTClassification code 10047371Term: Vesicoureteral refluxSystem Organ Class: 100000004857MedDRA version: 20.0Level: PTClassification code 10038433Term: Renal dysplasiaSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2013-000309-21-DEFondazione IRCCS Ca’ Granda” Ospedale Maggiore Policlinico436
进行中(未招募)
3 期
Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary TractRenal Hypodysplasia, Nonsyndromic, 1Chronic Kidney DiseaseVesicoureteral Reflux
NCT02021006Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico292
招募中
不适用
The influence of Maternal Antibiotic use on Microbial colonisation in Infants
NL-OMON26831VU medical center60